Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 24;24(9):5274–5289. doi: 10.1111/jcmm.15183

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

PTBP1 knock‐down potentiates the anti‐tumour effect of cisplatin on cisplatin‐resistant osteosarcoma in vivo. A, The treatment scheme. B, The general view of xenograft tumours in nude mice after 21 d of different treatments. C, Volume of xenograft tumours after 0, 7, 14 and 21 d of different treatments. D, Mass of xenograft tumours after 21 d of different treatments. E, Tunel assay determined the killing effect of different treatments on xenograft tumours in nude mice. Scale bar: 200 μm (40×). *P < .05